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Flux balance analysis (FBA) is a widely used tool for both the understanding and design of cell metabolism. Without 
any kinetic data, qualitative as well as quantitative predictions of metabolic flux activity to achieve optimal growth can 
be made. It is also computationally inexpensive as only linear problems need to be solved. Among its shortcomings, 
however, is the lack of a rigorous enforcement of the thermodynamical feasibility of reactions; this is due to the fact that 
FBA’s steady-state assumption evades the consideration of metabolite concentrations, which impact changes in Gibbs' 
free energies. Existing approaches to ensure thermodynamic feasibility are based on computationally expensive mixed-
integer linear programming. 
Here, we propose a Markov-Chain Monte-Carlo (MCMC) approach to identify metabolite concentrations that ensure 
thermodynamic feasibility. We sample metabolite concentration vectors, and use these to determine reaction 
directionalities that violate thermodynamic constraints. We then identify a biomass-producing FBA solution with minimal 
total flux F through these infeasible reactions. Solutions with lower F are deemed more likely, and hence the sampled 
concentrations are expected to converge towards thermodynamically feasible solutions. 
We compare our approach to existing ones with regard to solution spaces and runtime and give an overview of 
potential improvements. 
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Mannosylglycerate (MG) is a compatible solute with major potential applications in the cosmetic industry, as moisturizer 
and skin protector against UV damage, storage of vaccines and other biomaterials, or protein stabilizer in analytical 
and clinical kits. Since the production of MG is expensive the development of efficient production systems is mandatory 
to fully exploit the potential of this solute. Saccharomyces cerevisiae was selected to produce MG, which is synthesized 
by the condensation of GDP-mannose and 3-phosphoglycerate. To better understand the impact of this pathway in 
yeast metabolism, the two enzymatic reactions were accommodated and evaluated in silico using the yeast genome 
scale metabolic model IMM904. Several optimization algorithms were ran to find the sets of genetic modification that 
lead to maximization of MG production. Results show that the production can be optimized by increasing the flow 
towards GDP-mannose formation and by introducing a bottleneck in the synthesis of pyruvate. This metabolic 
engineering strategy that targets the increased supply of biosynthetic precursors was implemented in vivo. Results 
show that MG accumulation increases 1.5-fold by overexpressing the genes involved in formation of GDP-mannose. 
However, no effect in the production of MG was observed when 3-phosphoglycerate was overproduced. Moreover, 
higher yields of MG were obtained when the mutants were cultivated in chemostast in comparison with batch mode. 
 
